Sulfa hypersensitivity in patients with HIV infection: Onset, treatment, critical review of the literature

Wisconsin Medical Journal

Volumn 97, Issue 5, 1998, Pages 23-27

  Ryan, Charles ^a   Madalon, Michael ^a   Wortham, Donald W ^b   Graziano, Frank M ^a  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; SULFANILAMIDE;

ADULT; CLINICAL ARTICLE; CLINICAL PROTOCOL; DESENSITIZATION; DRUG HYPERSENSITIVITY; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MYALGIA; PNEUMOCYSTIS PNEUMONIA; RASH; RETROSPECTIVE STUDY; REVIEW;

EID: 0031809023     PISSN: 00436542     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. U.S. Public Health Service Task Force on antipneumocystis prophylaxis in patients with human immunodeficiency virus infection: Recommendations for prophylaxis against pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. J Acquir Immun Defic Syndr 1993; 6:46-55.
2. Wormser GP, Horowitz HW, Duncanson FP, Forseter G., Javaly K, Alompur SK, Gilroy SA, Lenox T, Rappaport A, Nadelmon RB: Low dose intermittent Trimethoprim-sulfamethoxazole for prevention of pneumocystis carinii pneumonia in patients with human immunodeficiency infection. Arch Int Med 1991; 151:688-692.
3. Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, Phillips L, Craven D, vanderHorst C, Feinberg J: A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995; 332:693-699.
4. Cribb AE, Lee BL, Trepanier LA, Spielberg SP: Adverse reactions to sulphanomide and sulphonamide-trimethaprim antimicrobials: clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev 1996; 15(1):9-50.
5. Jick H: Adverse reactions to Trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis 1982; 4:426-428.
6. Gordin FM, Simon GL, Wofsky CB, Mills J: Adverse reactions to Trimethoprim-sulfamethoxazole in patient with acquired immunodeficiency syndrome. Ann Int Med 1984; 100:495-499.
7. Hughes WT, LaFon SW, Scott JD, Masur H: Adverse events associated with Trimethoprim-sulfamethoxazole and Atovaquone during the treatment of AIDS-related pneumocystis carinii pneumonia. J Inf Dis 1995; 171:1295-1301.
8. Carr A, Penny R, Cooper DA: Efficacy and safety of rechallenge with low-dose Trimethoprim-sulfamethoxazole in previously hypersensitive HIV infected patients. AIDS 1993; 7:65-71.
9. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance definition for AIDS among adolescents and adults. MMWR 1992;41:RR-17.
10. Hennessey S, Strom BL, Berlin JA, Brennan PJ: Predicting cutaneous hypersensitivity reactions to cotrimoxazole in HIV-infected individuals receiving primary Pneumocystis Carinii pneumonia prophylaxis. J Gen Intern Med 1995; 10:380-386.
11. Primohamed M, Williams D, Tingle MD, Barry M, Khoo SH, O'Mahony C, Willans EG, Breckenridge AM, Park BK: Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency. AIDS 1996; 10:501-507.
12. Rieder MJ, Krause R, Bird IA, Dekaban GA: Toxicity of sulfonamide-reactive metabolites in HIV-infected and noninfected cells. J Acquir Immune Defic Syndr 1995; 9(2):134-140.
13. Lee B, Wong D, Benowitz NL, Sullum PM: Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome: Clin Pharm and Ther 1993; 53(5):529-535.
14. Gluckstein D, Ruskin J: Trimethoprim-sulfamethoxazole desensitization permits long term Pneumocystis prophylaxis in AIDS patients with prior TS intolerance. XXXII Interscience Conference on Antimicrobial Agents and Chemotherapy. Anaheim, October 1992; abstract 1475.
15. Nguyen MT, Walace MR, Weiss PJ, Bone WD, Kennedy CA: Trimethoprim sulfamethoxazole desensitization in HIV patients with previously documented TMP-SMX intolerance. Clin Infect Dis 1993; 3:563-570.
16. Bachmeyer C, Salmon D, Guerin C, Barre C, Hazebroucq G, Sicard D, Sereni D: Trimethoprim-Sulfamethoxazole desensitization in HIV-infected patients: an open study. AIDS 1995; 9:299-312.
17. Absar N, Daneshvar H, Beall G: Desensitization to Trimethoprim/sulfamethoxazole in HIV infected patients. J Allergy Clin Immunology June 1994; 93; 6:1001-1005.